QURE
Uniqure NV
Price:  
14.49 
USD
Volume:  
1,955,267.00
Netherlands | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

QURE EV/EBITDA

-590.2%
Upside

As of 2025-06-03, the EV/EBITDA ratio of Uniqure NV (QURE) is -7.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. QURE's latest enterprise value is 1,074.08 mil USD. QURE's TTM EBITDA according to its financial statements is -152.50 mil USD. Dividing these 2 quantities gives us the above QURE EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 16.8x - 23.6x 23.6x
Forward P/E multiples 16.9x - 26.7x 23.7x
Fair Price (52.09) - (70.98) (71.01)
Upside -459.6% - -590.0% -590.2%
14.49 USD
Stock Price
(71.01) USD
Fair Price

QURE EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-21 -7.41
2025-05-20 -7.34
2025-05-19 -7.12
2025-05-16 -6.76
2025-05-15 -6.60
2025-05-14 -6.38
2025-05-13 -6.44
2025-05-12 -6.56
2025-05-09 -6.43
2025-05-08 -6.24
2025-05-07 -5.45
2025-05-06 -5.96
2025-05-05 -7.55
2025-05-02 -7.15
2025-05-01 -7.23
2025-04-30 -7.14
2025-04-29 -6.82
2025-04-28 -6.86
2025-04-25 -6.93
2025-04-24 -6.96
2025-04-23 -7.01
2025-04-22 -7.01
2025-04-21 -6.61
2025-04-17 -6.51
2025-04-16 -5.21
2025-04-15 -5.31
2025-04-14 -5.13
2025-04-11 -5.05
2025-04-10 -4.92
2025-04-09 -5.13
2025-04-08 -4.84
2025-04-07 -4.99
2025-04-04 -5.06
2025-04-03 -5.34
2025-04-02 -5.66
2025-04-01 -5.40
2025-03-31 -5.65
2025-03-28 -6.32
2025-03-27 -6.55
2025-03-26 -6.74
2025-03-25 -7.00
2025-03-24 -7.15
2025-03-21 -6.76
2025-03-20 -6.84
2025-03-19 -6.88
2025-03-18 -6.62
2025-03-17 -7.06
2025-03-14 -6.94
2025-03-13 -6.79
2025-03-12 -6.63